Clinical Trials for Universal Allogeneic CAR T-cells

CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.

NCT ID: NCT06733610

This clinical trial is exploring a new treatment called CAR T-cell therapy for patients with a condition called Autoimmune Hemolytic Anemia (AIHA) who have not responded to at least three previous ...